Manufacturers of medicines, including Pfizer and Eli Lilly, have spent a combined $450,000 lobbying against price caps on ...

A modern control scheme and HD textures clash awkwardly with the boxy old levels of Lara's past, in three of her least ...

After testing the various models in Google's new Gemini 2.0 family, something interesting becomes clear: Google is exploring the potential of specialized AI systems working in concert similar to ...

The hormones you replace are not as protective as the hormone's you used to naturally produce, Shankar said. In fact, there ...

Vertex Pharmaceuticals recently obtained approval for its non-opioid pain medication. The drug could become a blockbuster and a key part of Vertex's portfolio. The stock has been rising in value ...

At least 49 cases of measles, mostly in children, have been confirmed in Gaines County, Texas. Health officials suspect 200 ...

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...

Here's why they think Eli Lilly (NYSE: LLY), Summit Therapeutics (NASDAQ: SMMT), and Vertex Pharmaceuticals (NASDAQ: VRTX) could trounce the market in 2025. David Jagielski (Eli Lilly): For years ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

After hours: February 14 at 5:37:46 PM EST Loading Chart for FORM ...